These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 1791843)

  • 1. Inhibition of estrogen receptor activity by the tumor promoter 12-O-tetradeconylphorbol-13-acetate: a molecular analysis.
    Tzukerman M; Zhang XK; Pfahl M
    Mol Endocrinol; 1991 Dec; 5(12):1983-92. PubMed ID: 1791843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Models of estrogen receptor regulation by estrogens and antiestrogens in breast cancer cell lines.
    Pink JJ; Jordan VC
    Cancer Res; 1996 May; 56(10):2321-30. PubMed ID: 8625307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FRA-1 expression level modulates regulation of activator protein-1 activity by estradiol in breast cancer cells.
    Philips A; Teyssier C; Galtier F; Rivier-Covas C; Rey JM; Rochefort H; Chalbos D
    Mol Endocrinol; 1998 Jul; 12(7):973-85. PubMed ID: 9658402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An estrogen receptor-alpha splicing variant mediates both positive and negative effects on gene transcription.
    Bollig A; Miksicek RJ
    Mol Endocrinol; 2000 May; 14(5):634-49. PubMed ID: 10809228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fos and Jun inhibit estrogen-induced transcription of the human progesterone receptor gene through an activator protein-1 site.
    Petz LN; Ziegler YS; Schultz JR; Nardulli AM
    Mol Endocrinol; 2004 Mar; 18(3):521-32. PubMed ID: 14684847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. cFos is critical for MCF-7 breast cancer cell growth.
    Lu C; Shen Q; DuPré E; Kim H; Hilsenbeck S; Brown PH
    Oncogene; 2005 Sep; 24(43):6516-24. PubMed ID: 16027729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcriptional activities of estrogen and glucocorticoid receptors are functionally integrated at the AP-1 response element.
    Uht RM; Anderson CM; Webb P; Kushner PJ
    Endocrinology; 1997 Jul; 138(7):2900-8. PubMed ID: 9202234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation and inhibition of the AP-1 complex in human breast cancer cells.
    Chen TK; Smith LM; Gebhardt DK; Birrer MJ; Brown PH
    Mol Carcinog; 1996 Mar; 15(3):215-26. PubMed ID: 8597534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogen receptor alpha and activating protein-1 mediate estrogen responsiveness of the progesterone receptor gene in MCF-7 breast cancer cells.
    Petz LN; Ziegler YS; Loven MA; Nardulli AM
    Endocrinology; 2002 Dec; 143(12):4583-91. PubMed ID: 12446585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retinoic acid receptors and retinoid X receptor-alpha down-regulate the transforming growth factor-beta 1 promoter by antagonizing AP-1 activity.
    Salbert G; Fanjul A; Piedrafita FJ; Lu XP; Kim SJ; Tran P; Pfahl M
    Mol Endocrinol; 1993 Oct; 7(10):1347-56. PubMed ID: 8264664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retinyl methyl ether down-regulates activator protein 1 transcriptional activation in breast cancer cells.
    Agadir A; Shealy YF; Hill DL; Zhang X
    Cancer Res; 1997 Aug; 57(16):3444-50. PubMed ID: 9270011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Functional interaction between estrogen receptor and proto-oncogene products c-Jun and c-Fos].
    Doucas V; Yaniv M
    C R Seances Soc Biol Fil; 1991; 185(6):464-74. PubMed ID: 1822395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional antagonism between the estrogen receptor and Fos in the regulation of c-fos protooncogene transcription.
    Ambrosino C; Cicatiello L; Cobellis G; Addeo R; Sica V; Bresciani F; Weisz A
    Mol Endocrinol; 1993 Nov; 7(11):1472-83. PubMed ID: 8114761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of 12-O-tetradecanoylphorbol-13-acetate on estrogen receptor activity in MCF-7 cells.
    Martin MB; Garcia-Morales P; Stoica A; Solomon HB; Pierce M; Katz D; Zhang S; Danielsen M; Saceda M
    J Biol Chem; 1995 Oct; 270(42):25244-51. PubMed ID: 7559663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effects of phorbol ester on epidermal growth factor receptors in estrogen receptor-positive and -negative breast cancer cell lines.
    Koga M; Musgrove EA; Sutherland RL
    Cancer Res; 1990 Aug; 50(16):4849-55. PubMed ID: 2379149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AP-1 transrepressing retinoic acid does not deplete coactivators or AP-1 monomers but may target specific Jun or Fos containing dimers.
    Suzukawa K; Colburn NH
    Oncogene; 2002 Mar; 21(14):2181-90. PubMed ID: 11948401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Down-regulation of messenger ribonucleic acid and protein levels for estrogen receptors by phorbol ester and calcium in MCF-7 cells.
    Ree AH; Landmark BF; Walaas SI; Lahooti H; Eikvar L; Eskild W; Hansson V
    Endocrinology; 1991 Jul; 129(1):339-44. PubMed ID: 2055193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and regulation of Cyr61 in human breast cancer cell lines.
    Tsai MS; Bogart DF; Li P; Mehmi I; Lupu R
    Oncogene; 2002 Jan; 21(6):964-73. PubMed ID: 11840342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Global gene expression analysis of estrogen receptor transcription factor cross talk in breast cancer: identification of estrogen-induced/activator protein-1-dependent genes.
    DeNardo DG; Kim HT; Hilsenbeck S; Cuba V; Tsimelzon A; Brown PH
    Mol Endocrinol; 2005 Feb; 19(2):362-78. PubMed ID: 15514030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. cJun overexpression in MCF-7 breast cancer cells produces a tumorigenic, invasive and hormone resistant phenotype.
    Smith LM; Wise SC; Hendricks DT; Sabichi AL; Bos T; Reddy P; Brown PH; Birrer MJ
    Oncogene; 1999 Oct; 18(44):6063-70. PubMed ID: 10557095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.